|
1
|
Spiro RH, Huvos AG, Berk R and Strong EW:
Mucoepidermoid carcinoma of salivary gland origin. A
clinicopathologic study of 367 cases. Am J Surg. 136:461–468. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar
|
|
3
|
Al- Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc NatI Acad Sci USA.
100:3983–3988. 2003.
|
|
4
|
Lapidot T, Sirard C, Vormoor J, et al: A
cell initiating human acute myeloid leukaemia after transplantation
into SCID mice. Nature. 367:645–648. 1994. View Article : Google Scholar
|
|
5
|
Liu S, Dontu G and Wicha MS: Mammary stem
cells, self-renewal pathways, and carcinogenesis. Breast Cancer
Res. 7:86–95. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galli R, Binda E, Orfanelli U, et al:
Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hemmati HD, Nakano I, Lazareff JA,
Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI:
Cancerous stem cells can arise from pediatric brain tumors. Proc
Natl Acad Sci USA. 100:15178–15183. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiba T, Kita K, Zheng YW, et al: Side
population purified from hepatocellular carcinoma cells harbors
cancer stem cell-like properties. Hepatology. 44:240–251. 2006.
View Article : Google Scholar
|
|
10
|
Li C, Heidt DG, Dalerba P, et al:
Identification of pancreatic cancer stem cells. Cancer Res.
67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
12
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang D, Nguyen TK, Leishear K, et al: A
tumorigenic subpopulation with stem cell properties in melanomas.
Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gibbs CP, Kukekov VG, Reith JD, et al:
Stem-like cells in bone sarcomas: implications for tumorigenesis.
Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beachy PA, Karhadkar SS and Berman DM:
Tissue repair and stem cell renewal in carcinogenesis. Nature.
432:324–331. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
18
|
Kamstrup MR, Gniadecki R and Skovgaard GL:
Putative cancer stem cells in cutaneous malignancies. Exp Dermatol.
16:297–301. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Setoguchi T, Taga T and Kondo T: Cancer
stem cells persist in many cancer cell lines. Cell Cycle.
3:414–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sunyou Z, Yi Z, Xu D and Xinghao Z: The
relationship between oral cancer HSP-70 expression and drug
sensitivity test in vitro. Shiyong Yixue Zazhi. 22:1839–1841.
2006.(In Chinese).
|
|
21
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar
|
|
22
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hirschmann-Jax C, Foster AE, Wulf GG, et
al: A distinct ‘side population’ of cells with high drug efflux
capacity in human tumor cells. Proc Natl Acad Sci USA.
101:14228–14233. 2004.
|
|
24
|
Chen JS, Pardo FS, Wang-Rodriguez J, et
al: EGFR regulates the side population in head and neck squamous
cell carcinoma. Laryngoscope. 116:401–406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou S, Schuetz JD, Bunting KD, et al: The
ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem
cells and is a molecular determinant of the side-population
phenotype. Nat Med. 7:1028–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Robinson SN, Seina SM, Gohr JC, Kuszynski
CA and Sharp JG: Evidence for a qualitative hierarchy within the
Hoechst-33342 ‘side population’ (SP) of murine bone marrow cells.
Bone Marrow Transplant. 35:807–818. 2005.PubMed/NCBI
|
|
27
|
Hadnagy A, Gaboury L, Beaulieu R and
Balickin D: SP analysis may be used to identify cancer stem cell
populations. Exp Cell Res. 312:3701–3710. 2006. View Article : Google Scholar
|
|
28
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar
|
|
29
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Goodwell MA and Brenner MK: A distinct ‘side population’ of cells
in human tumor cells: Implications for tumor biology and therapy.
Cell Cycle. 4:203–205. 2005.
|
|
30
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar
|
|
32
|
Loebinger MR, Giangreco A, Groot KR, et
al: Squamous cell cancers contain a side population of stem-like
cells that are made chemosensitive by ABC transporter blockade. Br
J Cancer. 98:380–387. 2008. View Article : Google Scholar
|
|
33
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Woodruff MF: Cellular heterogeneity in
tumours. Br J Cancer. 47:589–594. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haraguchi N, Ishii H, Mimori K, et al:
CD13 is a therapeutic target in human liver cancer stem cells. J
Clin Invest. 120:3326–3339. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Doyle LA, Yang W, Abruzzo LV, Krogmann T,
Gao Y, et al: A multidrug resistance transporter from human MCF-7
breast cancer cells. Proc Natl Acad Sci USA. 95:15665–15670. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Martin LP, Hamilton TC and Schilder RJ:
Platinum resistance: the role of DNA repair pathways. Clin Cancer
Res. 14:1291–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang M, Atkinson RL and Rosen JM:
Selective targeting of radiation resistant tumor-initiating cells.
Proc Natl Acad Sci USA. 107:3522–3527. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Madjd Z, Mehrjerdi AZ, Sharifi AM,
Molanaei S, Shahzadi SZ and Asadi-Lari M: CD44+ cancer cells
express higher levels of the anti-apoptotic protein Bcl-2 in breast
tumours. Cancer Immun. 9:42009.
|
|
41
|
Zobalova R, McDermott L, Stantic M,
Prokopova K, Dong LF and Neuzil J: CD133-positive cells are
resistant to TRAIL due to up-regulation of FLIP. Biochem Biophys
Res Commun. 373:567–571. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu G, Yuan X, Zeng Z, et al: Analysis of
gene expression and chemoresistance of CD133+ cancer stem cells in
glioblastoma. Mol Cancer. 5:672006.
|
|
43
|
Pan GJ, Chang ZY, Scholer HR and Pei D:
Stem cell pluripotency and transcription factor Oct4. Cell Res.
12:321–329. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kim JB, Sebastiano V, Wu G, et al:
Oct4-induced pluripotency in adult neural stem cells. Cell.
136:411–419. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu J, Vodyanik MA, Smuga-Otto K, et al:
Induced pluripotent stem cell lines derived from human somatic
cells. Science. 318:1917–1920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim JB, Zaehres H, Wu G, et al:
Pluripotent stem cells induced from adult neural stem cells by
reprogramming with two factors. Nature. 454:646–650. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jones TD, Ulbright TM, Eble JN, Baldridge
LA and Cheng L: OCT-4 staining in testicular tumors: a sensitive
and specific marker for seminoma and embryonal carcinoma. Am J Surg
Pathol. 28:935–940. 2004. View Article : Google Scholar
|
|
49
|
Tai MH, Chang CC, Kiupel M, Webster JD,
Olson LK and Trosko JE: Oct4 expression in adult human stem cells:
evidence in support of the stem cell theory of carcinogenesis.
Carcinogenesis. 26:495–502. 2005.PubMed/NCBI
|
|
50
|
Beltran AS, Rivenbark AG, Richardson BT,
et al: Generation of tumor-initiating cells by exogenous delivery
of OCT4 transcription factor. Breast Cancer Res. 13:R942011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ghisolfi L, Keates AC, Hu X, Lee DK and Li
CJ: Ionizing radiation induces stemness in cancer cells. PLoS One.
7:e436282012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Haynes BF, Liao HX and Patton KL: The
transmembrane hyaluronate receptor (CD44): multiple functions,
multiple forms. Cancer Cells. 3:347–350. 1991.
|
|
53
|
Zhang S, Balch C, Chan MW, et al:
Identification and characterization of ovarian cancer-initiating
cells from primary human tumors. Cancer Res. 68:4311–4320. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hurt EM, Kawasaki BT, Klarmann GJ, Thomas
SB and Farrar WL: CD44+ CD24(−) prostate cells are early cancer
progenitor/stem cells that provide a model for patients with poor
prognosis. Br J Cancer. 98:756–765. 2008.
|
|
55
|
Pries R, Witrkopf N, Trenkle T, Nitsch SM
and Wollenberg B: Potential stem cell marker CD44 is constitutively
expressed in permanent cell lines of head and neck cancer. In Vivo.
22:89–92. 2008.PubMed/NCBI
|
|
56
|
Kawabata S, Oka M, Soda H, et al:
Expression and functional analyses of breast cancer resistance
protein in lung cancer. Clin Cancer Res. 9:3052–3057.
2003.PubMed/NCBI
|
|
57
|
Al-Hajj M, Becker MW, Wicha M, Weissman I
and Clarke MF: Therapeutic implications of cancer stem cells. Curr
Opin Genet Dev. 14:43–47. 2004. View Article : Google Scholar
|
|
58
|
Dy GK, Hobday TJ, Nelson G, et al:
Long-term survivors of metastatic colorectal cancer treated with
systemic chemotherapy alone: a North Central Cancer Treatment Group
review of 3811 patients, N0144. Clin Colorectal Cancer. 8:88–93.
2009. View Article : Google Scholar
|
